Literature DB >> 32003663

Flavonoids as Multi-Target Compounds: A Special Emphasis on their Potential as Chemo-adjuvants in Cancer Therapy.

Ajay G Namdeo1, Sai H S Boddu2, Haneen Amawi3, Charles R Ashby4, Diwakar B Tukaramrao5, Piyush Trivedi1, R Jayachandra Babu6, Amit K Tiwari5.   

Abstract

Flavonoids are low molecular weight, polyphenolic phytochemicals, obtained from secondary metabolism of various plant compounds. They have a spectrum of pharmacological efficacies, including potential anticancer efficacy. Natural flavonoids are present in fruits, vegetables, grains, bark, roots, stems, flowers, tea and wine. Flavonoids can attenuate or inhibit the initiation, promotion and progression of cancer by modulating various enzymes and receptors in diverse pathways that involve cellular proliferation, differentiation, apoptosis, inflammation, angiogenesis and metastasis. Furthermore, in vitro, flavonoids have been shown to reverse multidrug resistance when used as chemo-adjuvants. Flavonoids (both natural and synthetic analogues) interact with several oncogenic targets through dependent and independent mechanisms to mediate their anticancer efficacy in different types of cancer cells. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Flavonoids; anti-cancer therapies; cancer cells; drug resistance; multi-targeted agents; secondary metabolism.

Mesh:

Substances:

Year:  2020        PMID: 32003663     DOI: 10.2174/1381612826666200128095248

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  1 in total

1.  Rhoifolin from Plumula Nelumbinis exhibits anti-cancer effects in pancreatic cancer via AKT/JNK signaling pathways.

Authors:  Bingxin Zheng; Yixin Zheng; Ningning Zhang; Yi Zhang; Baodong Zheng
Journal:  Sci Rep       Date:  2022-04-05       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.